[Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
D002648:Child; D002675:Child, Preschool; D003065:Coenzyme A / Q000097:blood; D003401:Creatine / Q000652:urine; D003402:Creatine Kinase / Q000097:blood; D003404:Creatinine / Q000652:urine; D004576:Electromyography; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D009136:Muscular Dystrophies / Q000188:drug therapy*; D010725:Phosphocreatine / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood
D010725:Phosphocreatine; D003404:Creatinine; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase; D003401:Creatine; D003065:Coenzyme A
Effetti della somministrazione di fosfocreatina sull'evoluzione clinica, biochemica ed elettromiografica della distrofia muscolare progressiva di Duchenne.